{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:45:47Z","timestamp":1784547947628,"version":"3.55.0"},"reference-count":44,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Interv Cardiol"],"abstract":"<jats:p>Several historical studies reported a higher rate of complications following transcatheter aortic valve replacement (TAVR) in women compared with men, especially major bleeding, vascular complications and stroke. More recent publications have demonstrated lower stroke rates following TAVR. The growing experience of modern TAVR operators played a crucial role in the reduction of early postprocedural stroke events. In addition, the improved transcatheter heart valve technology, the emphasis on a heart team-based selection process, and the inclusion of intermediate- and low-risk patients in the latest landmark randomised trials have all contributed to the lower stroke rates in contemporary trials. It is important to note, however, that at an individual level, stroke can significantly affect both quality of life and overall prognosis. Certain factors that increase the risk of periprocedural stroke include the distribution of calcification of native aortic valves, small aortic valve annuli, left ventricular dysfunction and fibrosis, and AF. These tend to occur more frequently in women. However, the role of cerebral embolic protection devices has not been shown to reduce procedure-related strokes in men or women. The overall incidence of factors predisposing to late-onset stroke is higher in women. Currently, there are no trials that have identified sex differences in the incidence and management of stroke following TAVR. This review aims to examine potential sex differences in the pathophysiology, preventive strategies and therapeutic options for stroke following TAVR.<\/jats:p>","DOI":"10.15420\/icr.2024.29","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:27:47Z","timestamp":1762252067000},"source":"Crossref","is-referenced-by-count":1,"title":["Sex Differences in Stroke Following Transcatheter Aortic Valve Replacement and the Role of Embolic Protection Devices in Women"],"prefix":"10.15420","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8714-0334","authenticated-orcid":false,"given":"Mirvat","family":"Alasnag","sequence":"first","affiliation":[{"name":"Cardiac Centre, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-6824","authenticated-orcid":false,"given":"Giulia","family":"Masiero","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2661-3246","authenticated-orcid":false,"given":"Chiara","family":"de Biase","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, Clinique Pasteur, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-7819","authenticated-orcid":false,"given":"Valeria","family":"Paradies","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, Maasstad Hospital, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-6247","authenticated-orcid":false,"given":"Marta","family":"Ka\u0142u\u017cna-Oleksy","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6096","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Eggebrecht H, Schmermund A, Voigtl\u00e4nder T, et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a\u00a0meta-analysis of 10,037 published patients. EuroIntervention 2012;8:129\u201338. https:\/\/doi.org\/10.4244\/EIJV8I1A20; PMID:\u00a022391581.","DOI":"10.4244\/eijv8i1a20"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Linder M, Seiffert M. Periprocedural strategies for stroke prevention in patients undergoing transcatheter aortic valve implantation. Front Cardiovasc Med 2022;9:892956. https:\/\/doi.org\/10.3389\/fcvm.2022.892956; PMID:\u00a035557539.","DOI":"10.3389\/fcvm.2022.892956"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Aroney N, Patterson T, Allen C, et al. Neurocognitive status after aortic valve replacement: differences between TAVI and surgery. J Clin Med 2021;10:1789. https:\/\/doi.org\/10.3390\/jcm10081789; PMID:\u00a033924077.","DOI":"10.3390\/jcm10081789"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Synnott P, Murphy RP, Judge C, et al. Stroke severity in transcatheter aortic valve implantation versus surgical aortic valve replacement: a systematic review and meta-analysis. J\u00a0Stroke Cerebrovasc Dis 2021;30:105927. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.105927; PMID:\u00a034252826.","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105927"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Meertens MM, Macherey S, Asselberghs S, et al. A\u00a0systematic review and meta-analysis of the cerebrovascular event incidence after transcatheter aortic valve implantation. Clin Res Cardiol 2022;111:843\u201358. https:\/\/doi.org\/10.1007\/s00392-022-01997-1; PMID:\u00a035298700.","DOI":"10.1007\/s00392-022-01997-1"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol 2021;77:2717\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.038; PMID:\u00a033888385.","DOI":"10.1016\/j.jacc.2021.02.038"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lansky AJ, Mess\u00e9 SR, Brickman AM, et al. Proposed standardized neurological endpoints for cardiovascular clinical trials: an Academic Research Consortium initiative. Eur Heart J 2018;39:1687\u201397. https:\/\/doi.org\/10.1093\/eurheartj\/ehx037; PMID:\u00a028171522.","DOI":"10.1093\/eurheartj\/ehx037"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Huded CP, Tuzcu EM, Krishnaswamy A, et al. Association between transcatheter aortic valve replacement and early postprocedural stroke. JAMA 2019;321:2306\u201315. https:\/\/doi.org\/10.1001\/jama.2019.7525; PMID:\u00a03121134.","DOI":"10.1001\/jama.2019.7525"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Ghanem A, Naderi AS, Frerker C, et al. Mechanisms and prevention of TAVI-related cerebrovascular events. Curr Pharm Des 2016;22:1879\u201387. https:\/\/doi.org\/10.2174\/1381612822666151217122610; PMID:\u00a026675314.","DOI":"10.2174\/1381612822666151217122610"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Mastoris I, Schoos MM, Dangas GD, Mehran R. Stroke after transcatheter aortic valve replacement: incidence, risk factors, prognosis, and preventive strategies. Clin Cardiol 2014;37:756\u201364. https:\/\/doi.org\/10.1002\/clc.22328; PMID:\u00a025403514.","DOI":"10.1002\/clc.22328"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Eschenbach LK, Erlebach M, Deutsch MA, et al. Stroke after transcatheter aortic valve replacement: a severe complication with low predictability. Catheter Cardiovasc Interv 2022;99:1897\u2013905. https:\/\/doi.org\/10.1002\/ccd.30143; PMID:\u00a035312220.","DOI":"10.1002\/ccd.30143"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Jakobsen L, Terkelsen CJ, S\u00f8ndergaard L, et al. Short- and long-term mortality and stroke risk after transcatheter aortic valve implantation. Am J Cardiol 2018;121:78\u201385. https:\/\/doi.org\/10.1016\/j.amjcard.2017.09.014; PMID:\u00a029103605.","DOI":"10.1016\/j.amjcard.2017.09.014"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Muralidharan A, Thiagarajan K, Van Ham R, et al. Meta-analysis of perioperative stroke and mortality in transcatheter aortic valve implantation. Am J Cardiol 2016;118:1031\u201345. https:\/\/doi.org\/10.1016\/j.amjcard.2016.07.011; PMID:\u00a027634034.","DOI":"10.1016\/j.amjcard.2016.07.011"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Krasopoulos G, Falconieri F, Benedetto U, et al. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries. J Cardiothorac Surg 2016;11:159. https:\/\/doi.org\/10.1186\/s13019-016-0552-6; PMID:\u00a027899128.","DOI":"10.1186\/s13019-016-0552-6"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kapadia S, Agarwal S, Miller DC, et al. Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER Trial (placement of aortic transcatheter valves). Circ Cardiovasc Interv 2016;9:e002981. https:\/\/doi.org\/10.1161\/circinterventions.115.002981; PMID:\u00a027601428.","DOI":"10.1161\/circinterventions.115.002981"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Masiero G, Tarantini G. Sex, antithrombotics, and outcomes after TAVR: is there more difference within sexes or between them? JACC Cardiovasc Interv 2023;16:1103\u20136. https:\/\/doi.org\/10.1016\/j.jcin.2023.03.051; PMID:\u00a037164610.","DOI":"10.1016\/j.jcin.2023.03.051"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Lansky A, Ghare MI, Tch\u00e9tch\u00e9 D, Baumbach A. TAVI and the brain: update on definitions, evidence of neuroprotection and adjunctive pharmacotherapy. EuroIntervention 2018;14:ab53\u201363. https:\/\/doi.org\/10.4244\/eij-d-18-00454; PMID:\u00a030158096.","DOI":"10.4244\/eij-d-18-00454"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Armijo G, Nombela-Franco L, Tirado-Conte G. Cerebrovascular events after transcatheter aortic valve implantation. Front Cardiovasc Med 2018;5:104. https:\/\/doi.org\/10.3389\/fcvm.2018.00104; PMID:\u00a030109235.","DOI":"10.3389\/fcvm.2018.00104"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Auffret V, Regueiro A, Del Trigo M, et al. Predictors of early cerebrovascular events in patients with aortic stenosis undergoing transcatheter aortic valve replacement. J\u00a0Am\u00a0Coll Cardiol 2016;68:673\u201384. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.065; PMID:\u00a027515325.","DOI":"10.1016\/j.jacc.2016.05.065"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Lindman BR, Goldstein JS, Nassif ME, et al. Systemic inflammatory response syndrome after transcatheter or surgical aortic valve replacement. Heart 2015;101:537\u201345. https:\/\/doi.org\/10.1136\/heartjnl-2014-307057; PMID:\u00a025605654.","DOI":"10.1136\/heartjnl-2014-307057"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Ko D, Rahman F, Schnabel RB, et al. Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol 2016;13:321\u201332. https:\/\/doi.org\/10.1038\/nrcardio.2016.45; PMID:\u00a027053455.","DOI":"10.1038\/nrcardio.2016.45"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Gorla R, Tua L, D\u2019Errigo P, et al. Incidence and predictors of 30-day and 6-month stroke after TAVR: insights from the multicenter OBSERVANT II study. Catheter Cardiovasc Interv 2023;102:1122\u201331. https:\/\/doi.org\/10.1002\/ccd.30848; PMID:\u00a037794734.","DOI":"10.1002\/ccd.30848"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Laricchia A, Bellini B, Romano V, et al. Sex and transcatheter aortic valve implantation: impact of female sex on clinical outcomes. Interv Cardiol 2019;14:137\u201341. https:\/\/doi.org\/10.15420\/icr.2019.07.R1; PMID:\u00a031867058.","DOI":"10.15420\/icr.2019.07.r1"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Spaziano M, Chieffo A, Watanabe Y, et al. Computed tomography predictors of mortality, stroke and conduction disturbances in women undergoing TAVR: a sub-analysis of the WIN-TAVI registry. J Cardiovasc Comput Tomogr 2018;12:338\u201343. https:\/\/doi.org\/10.1016\/j.jcct.2018.04.007; PMID:\u00a029735255.","DOI":"10.1016\/j.jcct.2018.04.007"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Miller DC, Blackstone EH, Mack MJ, et al. Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial. J Thorac Cardiovasc Surg 2012;143:832\u2013843.e13. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.01.055; PMID:\u00a022424519.","DOI":"10.1016\/j.jtcvs.2012.01.055"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Yoon CW, Bushnell CD. Stroke in women: a review focused on epidemiology, risk factors, and outcomes. J Stroke 2023;25:2\u201315. https:\/\/doi.org\/10.5853\/jos.2022.03468; PMID:\u00a036746378.","DOI":"10.5853\/jos.2022.03468"},{"key":"ref26","unstructured":"Herrmann HC, Mehran R, Blackman DJ, et al. Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus. N Engl J Med 2024;390:1959\u201371. https:\/\/doi.org\/10.1056\/NEJMoa2312573; PMID:\u00a038587261."},{"key":"ref27","unstructured":"Chieffo A, Petronio AS, Mehilli J, et al. Acute and 30-day outcomes in women after TAVR: results from the WIN-TAVI (Women\u2019s INternational Transcatheter Aortic Valve Implantation) real-world registry. JACC Cardiovasc Interv 2016;9:1589\u2013600. https:\/\/doi.org\/10.1016\/j.jcin.2016.05.015; PMID:\u00a027491609."},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Saad M, Nairooz R, Pothineni NVK, et al. Long-term outcomes with transcatheter aortic valve replacement in women compared with men: evidence from a meta-analysis. JACC Cardiovasc Interv 2018;11:24\u201335. https:\/\/doi.org\/10.1016\/j.jcin.2017.08.015; PMID:\u00a029055767.","DOI":"10.1016\/j.jcin.2017.08.015"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Khera S, Koshy AN, Tang GHL, et al. Prevention and management of stroke after transcatheter aortic valve replacement: the Mount Sinai Stroke Initiative. J Am Heart Assoc 2023;12:e028182. https:\/\/doi.org\/10.1161\/JAHA.122.028182; PMID:\u00a036752233.","DOI":"10.1161\/jaha.122.028182"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Schmidt T, Akdag O, Wohlmuth P, et al. Histological findings and predictors of cerebral debris from transcatheter aortic valve replacement: the ALSTER experience. J Am Heart Assoc 2016;5:e004399. https:\/\/doi.org\/10.1161\/JAHA.116.004399; PMID:\u00a027930358.","DOI":"10.1161\/jaha.116.004399"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Jimenez Diaz VA, Kapadia SR, Linke A, et al. Cerebral embolic protection during transcatheter heart interventions. EuroIntervention 2023;19:549\u201370. https:\/\/doi.org\/10.4244\/EIJ-D-23-00166; PMID:\u00a037720969.","DOI":"10.4244\/eij-d-23-00166"},{"key":"ref32","unstructured":"Kapadia SR, Kodali S, Makkar R, et al. Protection against cerebral embolism during transcatheter aortic valve replacement. J Am Coll Cardiol 2017;69:367\u201377. https:\/\/doi.org\/10.1016\/j.jacc.2016.10.023; PMID:\u00a027815101."},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Naber CK, Ghanem A, Abizaid AA, et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 2012;8:43\u201350. https:\/\/doi.org\/10.4244\/EIJV8I1A8; PMID:\u00a022403768.","DOI":"10.4244\/eijv8i1a8"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Isogai T, Bansal A, Vanguru HR, et al. Cerebral embolic protection and stroke- related mortality following transcatheter aortic valve replacement. JACC Cardiovasc Interv 2022;15:569\u201371. https:\/\/doi.org\/10.1016\/j.jcin.2022.01.007; PMID:\u00a035272784.","DOI":"10.1016\/j.jcin.2022.01.007"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Butala NM, Makkar R, Secemsky EA, et al. Cerebral embolic protection and outcomes of transcatheter aortic valve replacement: results from the transcatheter valve therapy registry. Circulation 2021;143:2229\u201340. https:\/\/doi.org\/10.1161\/circulationaha.120.052874; PMID:\u00a033619968.","DOI":"10.1161\/circulationaha.120.052874"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Van Mieghem NM, van Gils L, Ahmad H, et al. Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial. EuroIntervention 2016;12:499\u2013507. https:\/\/doi.org\/10.4244\/EIJV12I4A84; PMID:\u00a027436602.","DOI":"10.4244\/eijv12i4a84"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Alkhouli M, Alqahtani F, Harris AH, et al. Early experience with cerebral embolic protection during transcatheter aortic valve replacement in the United States. JAMA Intern Med 2020;180:783\u20134. https:\/\/doi.org\/10.1001\/jamainternmed.2019.6767; PMID:\u00a032091552.","DOI":"10.1001\/jamainternmed.2019.6767"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Kapadia SR, Makkar R, Leon M, et al. Cerebral embolic protection during transcatheter aortic-valve replacement. N\u00a0Engl J Med 2022;387:1253\u201363. https:\/\/doi.org\/10.1056\/NEJMoa2204961; PMID:\u00a036121045.","DOI":"10.1056\/NEJMoa2204961"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Kharbanda RK, Perkins AD, Kennedy J, et al. Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial. EuroIntervention 2023;18:1428\u201335. https:\/\/DOI.ORG\/10.4244\/EIJ-D-22-00713; PMID:\u00a036706009.","DOI":"10.4244\/EIJ-D-22-00713"},{"key":"ref40","unstructured":"Kharbanda RK, Kennedy J, Jamal Z, et al. Routine cerebral embolic protection during transcatheter aortic-valve implantation. N Engl J Med 2025;392:2403\u201312. https:\/\/doi.org\/10.1056\/NEJMoa2415120; PMID:\u00a040162661."},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Lansky AJ, Schofer J, Tchetche D, et al. A prospective randomized evaluation of the TriGuard\u2122 HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. Eur\u00a0Heart\u00a0J\u00a02015;36:2070\u20138. https:\/\/doi.org\/10.1093\/eurheartj\/ehv191; PMID:\u00a025990342.","DOI":"10.1093\/eurheartj\/ehv191"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Haussig S, Mangner N, Dwyer MG, et al. Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial. JAMA 2016;316:592\u2013601. https:\/\/doi.org\/10.1001\/jama.2016.10302; PMID:\u00a027532914.","DOI":"10.1001\/jama.2016.10302"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Kaur A, Dhaliwal AS, Sohal S, et al. Role of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: an updated meta-analysis. J\u00a0Am\u00a0Heart Assoc 2024;13:e030587. https:\/\/doi.org\/10.1161\/JAHA.123.030587; PMID:\u00a038240252.","DOI":"10.1161\/jaha.123.030587"}],"container-title":["Interventional Cardiology: Reviews, Research, Resources"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2024.29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:28:09Z","timestamp":1762252089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.icrjournal.com\/articleindex\/icr.2024.29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":44,"URL":"https:\/\/doi.org\/10.15420\/icr.2024.29","relation":{},"ISSN":["1756-1485","1756-1477"],"issn-type":[{"value":"1756-1485","type":"electronic"},{"value":"1756-1477","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"article-number":"e28"}}